Pain
📧 Sign up to get email alerts when something new happens for Pain.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-11-26Clinical Trial Update: Evaluation of Central Sensitization, Fear-Avoidance, and Pain-Pressure Threshold With Chronic Pain After Hysterectomy
A clinical trial update shows recruitment ongoing for a study examining central sensitization, fear-avoidance, and pain-pressure threshold i…
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: CPB for Arthroscopic Hip Surgery [NA]
A clinical trial registry entry evaluating CPB for pain management in arthroscopic hip surgery. The study is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-11-22Clinical Trial Update: Novel Stimulation Patterns to Improve the Effectiveness of Spinal Cord Stimulation [NA]
A clinical trial is recruiting to evaluate novel stimulation patterns to improve the effectiveness of spinal cord stimulation for chronic pa…
-
CLINICAL_TRIALS research · 2024-11-22Clinical Trial Update: The Effects of Performing a Motor Imagery Task on Cortical Excitability During Acute Experimental Muscle Pain and Acute Itch [NA]
This clinical trial update reports that the study is currently recruiting to assess how performing a motor imagery task influences cortical …
-
CLINICAL_TRIALS research · 2024-11-22Clinical Trial Update: Targeted Translocator Protein PET Imaging Evaluate Neuroinflammation of the Chronic Pain Patients
A PET imaging trial investigating neuroinflammation in chronic pain patients using a targeted translocator protein tracer; the study status …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-11-21FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for ketorolac tromethamine from Fresenius Kabi USA, LLC, indicating clearance of a modification …
-
FDA approval · 2024-11-21FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Ketorolac Tromethamine from Teva Pharmaceuticals USA, Inc., under an ANDA to update the approved…
-
FDA approval · 2024-11-21FDA Approved: HYDROCODONE BITARTRATE AND IBUPROFEN — Supplemental Application (Aurolife Pharma, LLC)
FDA approved a supplemental application for Hydrocodone Bitartrate and Ibuprofen from Aurolife Pharma, LLC.
-
FDA approval · 2024-11-21FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (Hospira, Inc.)
FDA approves Hospira's supplemental application for ketorolac tromethamine, a generic NSAID. The approval pertains to a supplemental change …
-
FDA approval · 2024-11-21FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (Chartwell RX, LLC)
The FDA approved Chartwell RX, LLC's supplemental application for ketorolac tromethamine (ANDA210616), confirming changes to the approved ge…
-
FDA approval · 2024-11-21FDA Approved: OXYCODONE AND ASPIRIN — Supplemental Application (Epic Pharma, LLC)
FDA approved a supplemental application for the Oxycodone and aspirin combination analgesic from Epic Pharma, LLC.
-
FDA approval · 2024-11-21FDA Approved: DICLOFENAC SODIUM — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for a generic diclofenac sodium product from NorthStar Rx LLC.
-
FDA approval · 2024-11-21FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (Eugia US LLC)
FDA approved a supplemental application for Ketorolac tromethamine (generic) from Eugia US LLC under ANDA 212939.
-
FDA approval · 2024-11-21FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (Civica, Inc.)
FDA approved a supplemental application for Civica's ketorolac tromethamine product, enabling a generic approval.
-
FDA approval · 2024-11-21FDA Approved: CELEBREX — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Celebrex (celecoxib) filed by Viatris Specialty LLC. The approval covers changes requested i…
-
FDA approval · 2024-11-21FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (Nephron Pharmaceuticals Corporation)
FDA approved a supplemental application for Ketorolac tromethamine filed by Nephron Pharmaceuticals Corporation under an ANDA.
-
FDA approval · 2024-11-21FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for Ketorolac Tromethamine by Alembic Pharmaceuticals Inc., indicating approval of an update to an e…
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: Improving Dysregulated Neural Networks With EEG-neurofeedback [NA]
This clinical trial update describes a study of EEG-neurofeedback to improve dysregulated neural networks. The study is currently enrolling …
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: The Effect of Projector Kaleidoscope and Cartoons on Anxiety, Fear, and Pain in Children [NA]
This completed clinical trial evaluated whether projector kaleidoscopes and cartoons reduce anxiety, fear, and pain in children undergoing s…
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: The Effect of Pain Education on Chiropractic Students' Understanding of Chronic Pain [NA]
This completed trial evaluated whether a pain education intervention improves chiropractic students' understanding of chronic pain.
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: Medullary Stimulation for the Treatment of Refractory Neck Pain (S2M) [NA]
Clinical study evaluating medullary stimulation for refractory neck pain is currently recruiting, sponsored by Nantes University Hospital.
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: Sensorimotor Cortex Excitability in Shoulder Impingement Syndrome
A clinical trial evaluating sensorimotor cortex excitability in shoulder impingement syndrome has completed. The study used transcranial mag…
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: A Retrospective Review of Rib Fracture Pain Management at a London Major Trauma Centre
This document reports a retrospective review of rib fracture pain management at a London major trauma centre. The study status is completed …
-
CLINICAL_TRIALS research · 2024-11-14Clinical Trial Update: Effect of Non-Invasive Neuromodulation on Primary Chronic Pain, Including Post-COVID-19 [NA]
The update covers a clinical study evaluating non-invasive neuromodulation for primary chronic pain, including Post-COVID Condition, with en…
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: A Multi-centre Observational Study of the Axium Neurostimulator as a Treatment for Chronic Pain
An observational multi-centre study evaluating the Axium Neurostimulator for chronic pain has completed and posted results.